Turkish League Against Rheumatism (TLAR) Recommendations for the Pharmacological management of Rheumatoid Arthritis: 2018 Update Under Guidance of Current Recommendations

Ataman, Sebnem; Sunar, Ismihan; Yilmaz, Gurkan; BODUR, HATİCE; Nas, Kemal; Ayhan, Fikriye; Akgul, Ozgur; AKINCI, AYŞEN; ALTAY, ZÜHAL; Birtani, Murat; Soy Bugdayci, Derya; Capkin, Erhan; Cevik, Remzi; Garip Cimen, Yesim; Duruoz, M.; Elhan, Atilla; Gurer, Gulcan; Kacar, Cahit; Kamanli, Ayhan; Kaptanoglu, Ece; Kaya, Taciser; Kocabas, Hilal; Kuru, Omer; ALKAN MELİKOĞLU, Meltem; Ozel, Sumru; Rezvani, Aylin; Sezer, Ilhan; Gul Yurdakul, Fatma

doi:10.5606/archrheumatol.2018.6911

Turkish League Against Rheumatism (TLAR) Recommendations for the Pharmacological management of Rheumatoid Arthritis: 2018 Update Under Guidance of Current Recommendations

Atıf İçin Kopyala

Ataman S., Sunar I., Yilmaz G., BODUR H., Nas K., Ayhan F. F., ...Daha Fazla

ARCHIVES OF RHEUMATOLOGY, cilt.33, sa.3, ss.251-272, 2018 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 33 Sayı: 3
Basım Tarihi: 2018
Doi Numarası: 10.5606/archrheumatol.2018.6911
Dergi Adı: ARCHIVES OF RHEUMATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.251-272
Anahtar Kelimeler: Disease modifying anti-rheumatic drugs, management, rheumatoid arthritis, treatment recommendations, Turkish League Against Rheumatism, MODIFYING ANTIRHEUMATIC DRUGS, NECROSIS-FACTOR INHIBITOR, LOW DISEASE-ACTIVITY, ADALIMUMAB PLUS METHOTREXATE, JOINT PROTECTION PROGRAM, HEAD-TO-HEAD, DOUBLE-BLIND, INADEQUATE RESPONSE, EULAR RECOMMENDATIONS, AMERICAN-COLLEGE
Atatürk Üniversitesi Adresli: Evet

Özet

Objectives: This study aims to report the assessment of the Turkish League Against Rheumatism (TLAR) expert panel on the compliance and adaptation of the European League Against Rheumatism (EULAR) 2016 recommendations for the management of rheumatoid arthritis (RA) in Turkey.